Diabète(sucré(et(embryopathie(à(la(thalidomide(
!"#$%&'()*+,-(.(-/-0#&"12(3*()*+,'(3#2)(/'()#24(
(
(
!-5"2"&"12(6(
7'(3"#$%&'(')&(*2'(8#/#3"'(/"-'(9(/#(3-5#"//#2+'(3'(/#(,-4*/#&"12(3*(&#*:(3'(4/*+1)'(3#2)(/'(
)#24(;#,(*2(8#2<*'(,'/#&"5(1*(#$)1/*(3="2)*/"2'>(
(
?&@81/14"'('&(A")&1",'(6(
7#(+/#))"5"+#&"12("2&',2#&"12#/'(*&"/")'(/'(&',8'(B(3"#$'&')(8'//"&*)(C(D(B(3"#$'&')(C(;,10"'2&(
3*(4,'+(#2+"'2('&()"42"5"'(;#))',(9(&,#0',)E(B(8'//"&*)(C(3*(/#&"2E()"42"5"#2&()*+,-(+188'(/'(
8"'/>(F')(&',8')(3-+,"0'2&(':#+&'8'2&(/')()@8;&G8')(;,"2+";#*:(3'(/#(8#/#3"'>(H,-&-'(3'(
F#;;#31+'(I'20",12(JK(L(MNK(#0>(O>PF>Q(#(1$)',0-(<*'(+',&#"2)(8#/#3')(3'0#"'2&(*,"2',(
5,-<*'88'2&(3%)(<*="/)(#0#"'2&($*('&(<*'(/'*,(*,"2'(#0#"&(*2(41R&()*+,-(I*2'(#;;,1+A'(
3"#421)&"<*'(+188*2'(;1*,(3"0',)')(#55'+&"12)(9(+'&&'(-;1<*'(-&#"&(3'(&')&',(/'(41R&(3'(
/=*,"2'Q>(7')(;,'8"%,')("23"+#&"12)(;1*,(&,#"&',(/=-8"))"12(':+'))"0'(3=*,"2'(12&(-&-(&,1*0-')(
MSKK(#0>(O>PF>(-+,"&')()*,(3')(,1*/'#*:(3'(;#;@,*)(-4@;&"'2)>(7=12(;,-)*8'(312+(<*'(+'&&'(
8#/#3"'(-&#"&(+122*'(3';*")($"'2(/124&'8;)>((
(
TA@)"1;#&A1/14"'(6(
7'(4/*+1)'(IB(/'()*+,'(CQ(')&(*2(51*,2"))'*,(3=-2',4"'("8;1,&#2&(D(+',&#"2)(&"))*)(I+188'(/'(
+',0'#*Q(3-;'23'2&(;,')<*'(':+/*)"0'8'2&(3'(/#(8-&#$1/")#&"12(3*(4/*+1)'(;1*,(1$&'2",(3'(
/=-2',4"'>((
7="2)*/"2'(')&(*2'(A1,812'(5#$,"<*-'(;#,(/'(;#2+,-#)('&(')&(,');12)#$/'(;1*,(/#(,-4*/#&"12(
3'(/#(4/@+-8"'(3#2)(/=1,4#2")8'>(7="2)*/"2'(5#01,")'(/=#$)1,$#&"12('&(/=*&"/")#&"12(3*(4/*+1)'(
;#,(/')(+'//*/')(3'(/=1,4#2")8'()'/12(/'*,($')1"2>(U2(+12)-<*'2+'E(/'(&#*:()#24*"2($#"))'>(
T#,#//%/'8'2&(/="2)*/"2'("2A"$'(/#()@2&A%)'(3'(4/*+1)'(3#2)(/'(51"'(I/'(51"'(;'*&()@2&A-&")',(
V*)<*=9(SKK4(3'(4/*+1)'(;#,(V1*,('&(/=-8'&&,'(3#2)(/'()#24Q>(
(
7'(8#2<*'(3="2)*/"2'(3#2)(/'()#24(1*(/#(,-)")&#2+'(;#&A1/14"<*'(3')(+'//*/')(;1*,(/#(
;-2-&,#&"12(3*(4/*+1)'('2&,#W2'(*2'(-/-0#&"12(3*(&#*:(3'()*+,'(3#2)(/'()#24(IA@;',4/@+-8"'Q(
'&(*2'($#"))'(3'(+'/*"P+"(3#2)(/')(+'//*/')>(((
(
X2'(A@;',4/@+-8"'('2&,#W2'(*2'(-/"8"2#&"12(,-2#/'(3*(4/*+1)'(;/*)(-/'0-'(<*'(/#(21,8#/'E(
0*(<*'(/')(+#;#+"&-)(3=#$)1,;&"12(3')(,'"2)()12&()#&*,-')>(7'()*,;/*)(3'(4/*+1)'(3#2)(/=*,"2'(
'2&,#W2'(;#,(1)81)'(*2()*,;/*)(3='#*(<*"(')&(#/1,)(-/"8"2-(;#,(*,"2#&"12>(H"2)"(/'(01/*8'(
3=*,"2'(#*48'2&'>(!=#*&,'(;#,&(/')(2"0'#*:(3'(4/*+1)'(-/'0-)(3122'(9(/=*,"2'(/'(41R&()*+,->(
7#(3"8"2*&"12(3'()*+,'(3#2)(/')(+'//*/')(#(;1*,(+12)-<*'2+'(*2'(,-3*+&"12(3'(/#(+#;#+"&-(
;A@)"<*'('&(8'2&#/'(#"2)"(<*=*2'(5#&"4*'>((
(
F18;/"+#&"12)(6(
H*&,'51")(/')(+18;/"+#&"12)(,'31*&-')(+188'(/'(+18#(3"#$-&"<*'(I&#*:(3'()*+,'()#24*"2(
)-0%,'8'2&(-/'0-Q(1*(/'(+A1+(A@;14/@+-8"<*'(I&#*:(3'()*+,'()#24*"2()-0%,'8'2&($#)Q(
8'2#"'2&()1*0'2&(9(/#(81,&>(Y,Z+'(#*:(&A-,#;"')(3");12"$/')(#+&*'//'8'2&E(+')(
+18;/"+#&"12)()12&(3'0'2*')(,#,')>((
(
7')(;,1$/%8')(;,"2+";#*:(3*(3"#$%&'(#*V1*,3=A*"()12&(/')(#/&-,#&"12)(3')(0#"))'#*:()#24*"2)6(
/')(A@;',4/@+-8"')(,-;-&-')('&(;,1/124-')(;,101<*'2&(*2'(4/@+1)@/#&"12(212(('2[@8#&"<*'(
I#++*8*/#&"12(3'()#++A#,"3')(3#2)(/')(;,1&-"2')Q(<*"('2&,#W2'(*2'(;',&'(3'(/#(512+&"12(3')(
;,1&-"2')('&('2(+12)-<*'2+'(/'*,(#++*8*/#&"12(3#2)(/')(&"))*)>((
U2(1*&,'E(/')(+12+'2&,#&"12)(-/'0-')(3'(4/*+1)'(3#2)(/')(&"))*)(212(3-;'23#2&)(3="2)*/"2'(
'23188#4'2&(;#,(1)81)'(/')(1,4#2')(I;#,(':'8;/'(/'(+,")&#//"2(3'(/=\"/(L(+#&#,#+&'(
3"#$-&"<*'Q>(
7')()-<*'//')(&#,3"0')(3*(3"#$%&'()12&(/'(,-)*/&#&(3')(/-)"12)(#*(2"0'#*(3')(0#"))'#*:(
)#24*"2)(;1*0#2&(#"2)"('2&,#W2',(*2("25#,+&*)(+#,3"#<*'E(*2(#++"3'2&(+-,-$,#/(0#)+*/#",'E(*2'(
"2)*55")#2+'(,-2#/'E(/#(2-+,1)'(3')(8'8$,')E(*2'(/-)"12(3')(@'*:('&(3')(2',5)>(7=#/&-,#&"12(3'(
/#()&,*+&*,'(3')(;,1&-"2')(;,101<*'(3')(&,1*$/')(3*()@)&%8'("88*2"&#",'('&('2(+12)-<*'2+'(
3')("25'+&"12)(5,-<*'2&')>((
(
F/#))"5"+#&"12(6((
!"55-,'2&')(3-5#"//#2+')(12&('2&,#"2-(*2'(+/#))"5"+#&"12(3')(3"0',)')(51,8')(3'(3"#$%&'E(312&(
/')(218)(12&()1*0'2&(+A#24-(#*(+1*,)(3')(3-+'22"')>(H+&*'//'8'2&(12(3")&"24*'(3'(5#]12(
)"8;/")&'(+')(51,8')(3'(3"#$%&'(6(
P !"#$%&'(3'(&@;'(M(
^+"(/=#$)'2+'(3="2)*/"2'(3#2)(/'()#24(')&(3*'(9(*2'(3')&,*+&"12(3=1,"4"2'("2+122*'(3')(
+'//*/')($_&#(3')(W/1&)(3*(;#2+,-#)(I<*"(;,13*")'2&(/="2)*/"2'Q>(7#(8#/#3"'(;'*&(
#;;#,#W&,'(3'(8#2"%,'()1*3#"2'E('2(/=');#+'(3'(<*'/<*')(V1*,)('&(&1*+A'()*,&1*&(/')(
'25#2&)(#*&1*,(3'(MK(#2)>(7=12()*);'+&'(3')(;,1+%)("88*21/14"<*')E(*2'(3");1)"&"12(
4-2-&"<*'(1*(3')("25'+&"12)(0",#/')(9(/=1,"4"2'(3'(+'&&'(8#/#3"'>(7'(&,#"&'8'2&(,';1)'(
)*,(/="2V'+&"12(<*1&"3"'22'('&(,-4*/"%,'(3="2)*/"2'('&(*2'(#3#;&#&"12(3*(,-4"8'(
#/"8'2&#",'>(
P !"#$%&'(3'(&@;'(`(
!#2)(+'(+#)E(12(1$)',0'(*2(3-)-<*"/"$,'(3'(/#(,-4*/#&"12(3'(/#(4/@+-8"'()*"&'(9(*2'(
,-)")&#2+'(#++,*'(3')(,-+';&'*,)(3')(+'//*/')('20',)(/="2)*/"2'('&(9(*2'(3"8"2*&"12(
+12)&#2&'(3'(/#(;,13*+&"12(3="2)*/"2'(3*(;#2+,-#)>(F'&&'(8#/#3"'(')&()1*0'2&(
)"/'2+"'*)'(3*,#2&(3')(#22-')('&(')&(3-+1*0',&'(;#,(A#)#,3(/1,)(3=':#8'2)(3'(
,1*&"2'(1*(3'(+18;/"+#&"12)>(!"55-,'2&')(+#*)')()12&(3")+*&-')(6(/#(3");1)"&"12(
4-2-&"<*'E(*2'(#/"8'2&#&"12(3-)-<*"/"$,-'('&(,"+A'('2(4,#"))'E(/=':+%)(3'(;1"3)('&(/'(
8#2<*'(3=#+&"0"&-(;A@)"<*'>((
a12(&,#"&'8'2&(+12)")&'('2(*2(&,#"&'8'2&(8-3"+#8'2&'*:(I;"/*/')(;,")')(;#,(01"'(
1,#/'($/1<*#2&(/#(;,13*+&"12(3'(4/*+1)'(1*()&"8*/#2&(/#(;,13*+&"12(3="2)*/"2'(3#2)(/'(
;#2+,-#)Q>(!#2)(+',&#"2)(+#)("/(')&("23");'2)#$/'(3'(+18;/-&',(/'(&,#"&'8'2&(#0'+(3')((
"2V'+&"12)(3="2)*/"2'>(U2(1*&,'(*2'(#/"8'2&#&"12(-<*"/"$,-'E(/=#+&"0"&-(;A@)"<*'(#"2)"(
<*'(/#(,-3*+&"12(3*(;1"3)()12&(&,%)("8;1,&#2&')>(((((
P H*&,')(+#*)')(6(3"#$%&'(9(/#()*"&'(3=*2'(+A",*,4"'(I#$/#&"12Q(3*(;#2+,-#)E(3"#$%&'(
4')&#&"122'/(I#;;#,#"))#2&(3*,#2&(/#(4,1))'))'QE(3"#$%&'("23*"&(;#,(*2(8-3"+#8'2&(
I;#,(':'8;/'(/#(+1,&")12'Q(1*()@23,18'(4-2-&"<*'>(
(
!"#421)&"+(6(
7'(3"#421)&"+()'(5#"&(;#,(3')(#2#/@)')(3'()#24(6(/'(4/*+1)'E(/'(b$HM+(IA-814/1$"2'(4/@<*-'(
"23"<*#2&(/#(81@'22'((3'(4/@+1)'(3#2)(/'()#24()*,(&,1")(81")Q('&(/=A@;',4/@+-8"'(;,101<*-'(
;#,(01"'(1,#/'(I8')*,'(3'(/#(4/@+-8"'(9(V'*2E(;*")(*2'('&(3'*:(A'*,')(#;,%)(/="24')&"12(3=*2'(
+',&#"2'(31)'(3'(4/*+1)'Q>((
(
T,-0#/'2+'(6(
7'(3"#$%&'(')&(+12)"3-,-(+188'(B(/#(;')&'(3*(`M"%8'()"%+/'(C>(a#(;,-0#/'2+'(#*48'2&'(
;#,#//%/'8'2&(9(/=1$-)"&-('&(/=#/"8'2&#&"12(A@;',+#/1,"<*'>(7'(3"#$%&'(')&(*2'(8#/#3"'(
;#,&"+*/"%,'8'2&(,-;#23*'(3#2)(/')(;#@)(3'(/=1*')&("23*)&,"#/")-)>((
a'/12(/')(+#"))')(8#/#3"'('2(H//'8#42'E(12(+18;&'('20",12(Jc(3'(3"#$-&"<*')(3'(&@;'(`(I)1"&(
dEN(8"//"12)QM()1*)(&,#"&'8'2&(8-3"+#/>(F'(218$,'(2'(+18;,'23(;#)(/')(;',)122')E(+A'[(
/')<*'/)(/'(3"#$%&'(2=#(;#)(-&-(3"#421)&"<*->((
(
Évaluation(de(la(question(:(le(diabète(fait<il(partie(du(syndrome(dû(à(la(thalidomide(?(
(
7#(+188"))"12(8-3"+#/'(3')(0"+&"8')(3'(/#(&A#/"318"3'()'(01"&()#2)(+'))'(+125,12&-'(9(+'&&'(
<*')&"12>(7')(3'8#23')(+12+',2'2&('2(8#V1,"&-(/'(3"#$%&'(3'(&@;'(`('&()')(8#2"5')&#&"12)(9(
/=Z4'(#3*/&'>((
(
71,)(3'(/#(,-3#+&"12(3'(+'&(#,&"+/'(IKef`KMNQE((/#($#2<*'($"$/"14,#;A"<*'(3'(3122-')(T*$8'3(
2=#(#55"+A-(#*+*2'(;*$/"+#&"12(/1,)(3'(/#(,'+A',+A'(#0'+(/')(81&)(+/'5)('8$,@1;#&A"'(3R(9(/#(
&A#/"318"3'('&(3"#$%&'>((
(
F188'(8'2&"122-(+"P3'))*)E(/'(3"#$%&'(')&(+#*)-(;#,(3'(8*/&";/')(5#+&'*,)('&(')&(&,%)(
,-;#23*('2(H//'8#42'>((
(
a'/12(/#(+188"))"12(8-3"+#/'(/="24')&"12(3'(/#(&A#/"318"3'(3*,#2&(/#(4,1))'))'(2="8;/"<*'(
;#)(*2(3"#$%&'(9(/=Z4'(#3*/&'>(
(
T1*,<*1"(*2'(,'/#&"12('2&,'(/#(&A#/"318"3'('&(/'(3"#$%&'(')&P'//'(;'*(;,1$#$/'(g(
(
M> 7="2A"$"&"12()-/'+&"0'(3'(/#(+,1"))#2+'(3=*2'()'*/'(/"42-'(3'(+'//*/')6(
7'(;#2+,-#)(')&(*2(1,4#2'(#0'+(*2'(512+&"12('231+,"2'(I;,13*+&"12(3="2)*/"2'(3#2)(
/')(+'//*/')($_&#E(-8"))"12(3'(/="2)*/"2'(3#2)(/'()#24Q('&(*2'(512+&"12(':1+,"2'(
I;,13*+&"12(3'(3"55-,'2&')(A1,812')(-8")(3#2)(/'(3*13-2*8Q>(h1*)(/')(3'8#23'*,)(
3="23'82")#&"12(-&#"'2&(3')(&A#/"318"3"'2)()1*55,#2&(*2"<*'8'2&(3=*2'(512+&"12(
'231+,"2'(3-,#24-'>(F'+"()"42"5"',#"&(<*'(/#(&A#/"318"3'("2A"$'()-/'+&"0'8'2&(/')(
+'//*/')($_&#E(3'(5#]12(9(+'(<*='//')(2'(;',3'2&(/'*,(512+&"12(<*=#;,%)(/=Z4'(3'(iS(9(
SK(#2)(I+#,(/')(;#&"'2&)(#55'+&-)(2=#0#"'2&(;#)(3'(3"#$%&'(3*,#2&(/'*,('25#2+'Q>(a'/12(
/')(+122#"))#2+')(#+&*'//')(*2'(51,8#&"12(A@;1;/#)"<*'()-/'+&"0'(3')(W/1&)(3*(
;#2+,-#)(')&(;'*(;,1$#$/'(3=#*&#2&(;/*)(<*=*2'(/"42-'(3'(+'//*/')(A@;1;/#)"<*'(;'*&E(
3#2)(+',&#"2')(+123"&"12)E(512+&"122',(&1*&'(/#(0"'>(
^/(')&(312+(;'*(;,1$#$/'(<*'(/#(+#*)'(3')(+'//*/')($_&#('23188#4-')(;,10"'22'(
3=*2'("2A"$"&"12(3'(+,1"))#2+'(3*,#2&(/#(4,1))'))'>(
(
`> 7=#;;#,"&"12(&#,3"0'(3'(/#(8#/#3"'6(
7='8$,@1;#&A"'(3*'(9(/#(&A#/"318"3'(')&(*2()@23,18'(3'(8#/51,8#&"12)(+124-2"&#/')(
3')(':&,-8"&-)('&(3'(3"55-,'2&)(1,4#2')>(7')(8#/51,8#&"12)(1$)',0-')(-&#"'2&(
;,-)'2&')(3';*")(/#(2#"))#2+'(8_8')()"(+',&#"2')(I#4-2-)"'(3=*2(,'"2E(8#/51,8#&"12(
3*(0#4"2('&(3'(/=*&-,*)Q(12&()'*/'8'2&(-&-(3-+1*0',&')(9(/=Z4'(#3*/&'>(!#2)(/'(+#)(3*(
3"#$%&'E(+';'23#2&E(/')(W/1&)(12&(512+&"122-(3*,#2&(3')(#22-')>((
(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((
M(!'*&)+A',(Y')*23A'"&)$',"+A&(!"#$'&')(`KMKE(;>e(
7#(+188"))"12(8-3"+#/'(2'(+122#"&(;#)(3'(+#)(3'(3"#$%&'(+124-2"&#/(+A'[(/')(
&A#/"318"3"'2)(V*)<*=9(+'(V1*,>(
(
j-)*8-(6(H+&*'//'8'2&E(/#(+188"))"12(8-3"+#/'(&,#"&'(/'(3"#$%&'(+188'(8#/#3"'(2'(
,-)*/&#2&(;#)(3'(/="24')&"12(3'(/#(&A#/"318"3'(3*,#2&(/#(4,1))'))'>((
(
Pourquoi(donc(beaucoup(de(personnes(affectées(pensent<elles(souffrir(fréquemment(du(
diabète(?(
(
O*)<*=9(;,-)'2&E(#*+*2'(;*$/"+#&"12(2'(3-+,"&(/#(;,-0#/'2+'(3'(3"#$%&'(+A'[(/')(
&A#/"318"3"'2)(6(312+E(/=12(2'(;'*&(#))*8',(<*'(/')(&A#/"318"3"'2)()1*55,'2&(;/*)()1*0'2&(
3*(3"#$%&'(<*'(/#(;1;*/#&"12(21,8#/'>(a"(/=12(&,#2);1)'(/#(5,-<*'2+'(3'(3"#$%&'(3'(&@;'(`(3'(
/#(;1;*/#&"12(21,8#/'(3=#;;,1:"8#&"0'8'2&(Jc((#*:(&A#/"318"3"'2)E(12()=#&&'23,#"&(
)&#&")&"<*'8'2&(9(+'(<*'(`Md(3')(`kKK(&A#/"318"3"'2)('2(H//'8#42'()1*55,'2&(#+&*'//'8'2&(
1*(3#2)(/')(#22-')(9(0'2",(3=*2(3"#$%&'(3'(&@;'(`>(l*(<*'(/'(,#;;1,&(3"#$-&"<*'(2'(+/#))"5"'(
;#)(;#,(&,#2+A'(3=Z4'E(+'(+A"55,'(2'(;#,#W&(;#)(&,%)(':#+&>(a'/12(*2'(;*$/"+#&"12(3'(/="2)&"&*&(
j1$',&(m1+A(('2(H//'8#42'E(/=12(')&"8'(/#(;,-0#/'2+'(3'(3"#$%&'(I3'(&@;')(M('&(`Q(+A'[(/')(
;',)122')(Z4-')(3'(iK(9(ie(#2)(9(81"2)(3'(ScE(+A'[(+'//')(Z4-')(3'(SK(9(Se(#2)(9(;/*)(3'(
ec`>(((
(
^/(5#*&(#/1,)()=#&&'23,'(9(+'(<*'(/')(&A#/"318"3"'2)(3-0'/1;;'2&(*2(3"#$%&'(#0'+(/=Z4'E(
)*,&1*&(3#2)(/#(S"%8'(3-+#3'(3'(/'*,(0"'>((
(
F188'(8'2&"122-(+"P3'))*)E("/(2n@(#(#+&*'//'8'2&(;#)(3=-0"3'2+'(<*'(/#(&A#/"318"3'(+#*)'(
3",'+&'8'2&(*2(3"#$%&'>((
(
7=12(;1*,,#"&(+';'23#2&(;'2)',(9(*2'(,'/#&"12("23",'+&'(0*(<*'(/#(&A#/"318"3'('24'23,'(*2(
A#23"+#;(;A@)"<*'('&(+'/*"P+"(;#,(*2(8#2<*'(3=#+&"0"&-(;A@)"<*'(*2(3"#$%&'>(U2('55'&E(
/=#55",8#&"12(<*'(/'(8#2<*'(3=#+&"0"&-('&(/=1$-)"&-()12&(3')(5#+&'*,)(3'(,")<*'(;1*,(/'(3"#$%&'(
')&($"'2(;,1*0-'>((
7')(;',51,8#&"12)();1,&"0')(5#2&#)&"<*')(3'(+',&#"2)(&A#/"318"3"'2)(312&(,#;;1,&'2&(/')(
8-3"#)(2'(;'*0'2&(;#)(_&,'(4-2-,#/")-)(;1*,(&1*&')(/')(;',)122')(0"+&"8')(3'(/#(
&A#/"318"3'>((U2(,-#/"&-(/')(8#/51,8#&"12)(3')(':&,-8"&-)(,'23'2&(/')(#+&"0"&-)();1,&"0')(&,%)(
3"55"+"/')(;1*,(/')(&A#/"318"3"'2)('&($'#*+1*;()1*55,'2&(3'()*,;1"3)>((
(
X2'(,'/#&"12("23",'+&'()'8$/'(312+(_&,'(;/#*)"$/'('2(+12)&#&#2&(/#(+A#W2'(3=#+&"12()*"0#2&'(6(((
Malformations,dues,à,la,thalidomide,2>,handicap,2>,activité,physique,et,sportive,réduite,2>,
obésité,2>,syndrome,métabolique,2>,diabète.,
(
X2'("23'82")#&"12(5"2#2+"%,'(3*'(9(/=A#23"+#;(3*(3"#$%&'(+A'[(/')(&A#/"318"3"'2)(2=')&(;#)(
;,-0*'(3'(21)(V1*,)E(0*(<*="/(2'()=#4"&(;#)(3=*2(A#23"+#;(;A@)"<*'(3",'+&'8'2&(#))1+"-(9(/#(
&A#/"318"3'>(((
(
o(/=-;1<*'(1p(/#(5123#&"12(3')(0"+&"8')(3'(/#(&A#/"318"3'(#(-&#$/"(*2'(-+A'//'(3'(0#/'*,)(
;1*,(/')(;,')&#&"12)E(/=12(2=#(;,1$#$/'8'2&(;#)(&'2*(+18;&'(3')(3188#4')(+1,;1,'/)(
(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((
`(Publikation du Robert Koch Institut 03/2011 : Diabetes mellitus in Deutschland. Zahlen und Trends aus der
Gesundheitsberichterstattung des Bundes, p. 2, http
://www.rki.de/DE/Content/Gesundheitsmonitoring/Gesundheitsberichterstattung/GBEDownloadsK/2011_3_diabetes.pdf?
__blob=publicationFile(
3-+1*/#2&(3'(/#(&A#/"318"3'('&(3*(5#"&(<*'(/=A#23"+#;(;A@)"<*'('24'23,'(*2'(#+&"0"&-(
;A@)"<*'(/"8"&-'(#0'+(&1*&')(/')(+18;/"+#&"12)(+12)-+*&"0')>(!=#*&,'(;#,&(/=12()'()=#&&'23#"&(
;#)(9(+'(<*'(/')(0"+&"8')(3'(/#(&A#/"318"3'(#&&'"23,#"'2&(*2(Z4'()"(#0#2+-E(1p(+'(;,1$/%8'(
;1*,,#"&(#01",(*2'("8;1,&#2+'(3*(;1"2&(3'(0*'(8-3"+#/>(
(
(
M`f`KMi(!,>(O>(a+A*/&'Pb"//'2(f(!,>(a'/8#(U/(m#))'8(((
(
1 / 5 100%
La catégorie de ce document est-elle correcte?
Merci pour votre participation!

Faire une suggestion

Avez-vous trouvé des erreurs dans linterface ou les textes ? Ou savez-vous comment améliorer linterface utilisateur de StudyLib ? Nhésitez pas à envoyer vos suggestions. Cest très important pour nous !